Covid 19 vaccine maker Moderna designed its vaccine against the novel coronavirus in just two days . 
On Jan . 11 , Chinese authorities shared the genetic sequence of the novel coronavirus , according to Moderna 's website . 
Two days later , on Jan . 13 , the National Institutes of Health and Moderna â€™s infectious disease research team finalized the sequence for m RNA 1273 , the formal name of the company 's Covid 19 vaccine . 
The company then went on to formulate a clinical batch , according to a company spokesperson . 
Moderna announced it intends to apply today to the US Food and Drug Administration for authorization of its Covid 19 vaccine . 
The company will ask the FDA to review an expanded data set showing the vaccine is 94.1 % effective at preventing Covid 19 and 100 % effective at preventing severe cases of the disease . 
